Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions. The company seeks to acquire and/or develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the benefits they may have in certain cases involving depression, mental health issues, and neurological disorders. The company focuses on merging traditional therapeutics with psychedelic research for people suffering from indications, such as depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [06/08/2026 16:11 PDT] Silo Pharma, Inc. (NASDAQ:SILO), Up By 100% ($5.42) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, June 3rd 2026 at a Price of $5.42.
• [06/04/2026 08:10 PDT] SILO Expected to Trade Up After Bullish Patterns Develop
• [06/03/2026 10:29 PDT] SILO SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/03/2026 10:29 PDT] Silo Pharma, Inc. (NASDAQ:SILO), Up By 100% ($0.39) From $0.39 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [05/14/2026 07:06 PDT] SILO Expected to Trade Up After Bullish Patterns Develop
• [05/01/2026 07:23 PDT] SILO Expected to Trade Up After Bullish Patterns Develop
• [04/23/2026 07:46 PDT] Silo Pharma, Inc. (NASDAQ:SILO), Down By 100% ($0.58) From $0.58 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [04/23/2026 04:24 PDT] SILO Expected to Trade Down After Bearish Patterns Develop
• [04/22/2026 09:51 PDT] Silo Pharma, Inc. (NASDAQ:SILO), Up By 100% ($0.52) From $0.52 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/21/2026 09:27 PDT] SILO Expected to Trade Up After Bullish Patterns Develop